Parnax Lab Ltd - 506128 - Compliance Certificate For The Period Ended March 31, 2019
Please find enclosed herewith the Certificate as per Regulation 7(3) of the Listing Obligations for the year ended 31st March, 2019.16-04-2019
16-04-2019
PARNAX LAB LTD. - 506128 - Shareholding for the Period Ended March 31, 2019
Parnax Lab Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here12-04-2019
Parnax Lab Ltd - 506128 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Bhoomi ThakkarDesignation :- Company Secretary and Compliance Officer11-04-2019
Parnax Lab Ltd - 506128 - Closure of Trading Window
Pursuant to SEBI(Prohibition of Insider Trading) Regulations, 2015 as amended and as per Company's Code of Conduct for prevention of Insider Trading, read with BSE Circular No. LIST/COMP/01/2019-20 dated April 2, 2019, the Trading Window for dealing in securities of the Company is closed for all Directors, Designated Employees and other persons covered under the Code from 3rd April, 2019 till the expiry of 48 hours after the declaration of the Financial Results for the quarter/year ended March 31, 2019.03-04-2019
Parnax Lab Ltd - 506128 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Pursuant to the Regulation 8 (2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended by SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, the Board of Directors of the Company has revised the Company's 'Code for Fair Disclosure of Unpublished Price Sensitive Information'. Pursuant to the Regulation 8 (2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 we are forwarding herewith the revised code, which shall be effective from April 1, 2019.30-03-2019
Parnax Lab Ltd - 506128 - Outcome of Board Meeting
Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we wish to inform you that in the meeting of the Board of Directors of the Company held on Wednesday, 27th March 2019 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of re-appointment of Mr. Vinayak Babli Desai (DIN: 03185850) as a Non-Executive Independent Director of the Company for second term of 5 consecutive years for the period starting from 1st April, 2019 to 31st March, 2024, subject to approval of the members in the ensuing Annual General Meeting. 2. Approval of re-appointment of Mr. Manharbhai Navalchand Jhavari (DIN: 03571525) as a Non-Executive Independent Director of the Company for second term of 5 consecutive years for the period starting from 1st April, 2019 to 31st March, 2024, subject to approval of the members in the ensuing Annual General Meeting. The Meeting commenced at 4.00 p.m. and concluded at 4.45 p.m.27-03-2019
PARNAX LAB LTD. - 506128 - Results- Financial Results For The Quarter Ended December 31, 2018.
Kindly find enclosed herewith the following: 1. The Copy of Standalone & Consolidated Un-Audited Financial results with Limited Review Report of the Company for the quarter ended 31st December, 2018.13-02-2019
Parnax Lab Ltd - 506128 - Outcome of Board Meeting
Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we wish to inform you that in the meeting of the Board of Directors of the Company held on Wednesday,13th February 2019 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Un-Audited Standalone & Consolidated Financial Results as submitted by statutory auditor of the Company for the quarter ended December 31, 2018. 2. Considered and took note of Limited Review Report for the quarter ended December 31, 2018. The Meeting commenced at 3.30 p.m. and concluded at 4.00 p.m.13-02-2019
Parnax Lab Ltd - 506128 - Closure of Trading Window
On account of declaring the Un-audited financial (Standalone and Consolidated) results for the quarter ended on 31st December, 2018 and as per Company's Code of Conduct for prevention of Insider Trading, the Trading Window for dealing in securities of the Company is closed for all Directors, Designated Employees and other persons covered under the Code from 5th February, 2019 till the expiry of 48 hours after the public announcement of the said results are made.02-02-2019
Parnax Lab Ltd - 506128 - Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended December 31, 2018
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2019 ,inter alia, to consider and approve 1.Standalone and Consolidated Un-audited IND-AS compliant Financial Results along with Limited Review Report for the quarter ended 31st December, 2018 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2.Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director.02-02-2019